Tell your friends about this item:
Resistance to Anti Cancer Therapeutics Targeting Receptor Tyrosine Kinases and D 1st ed. 2018 edition
Resistance to Anti Cancer Therapeutics Targeting Receptor Tyrosine Kinases and D
This volume comprehensively covers the multiplicity and diversity of mechanisms underlying patient resistance to currently approved anti-cancer drugs, including tyrosine kinase inhibitors and monoclonal antibodies, blockers of growth factor receptors and their downstream pathways, which play essential functions in cancer progression.
240 pages, 22 Illustrations, color; XX, 240 p. 22 illus. in color.
| Media | Books Book |
| Released | April 10, 2018 |
| ISBN13 | 9783319679303 |
| Publishers | Springer International Publishing AG |
| Pages | 242 |
| Dimensions | 150 × 220 × 20 mm · 565 g |
| Language | German |
| Editor | Elkabets, Moshe |
| Editor | Yarden, Yosef |